Abstract. Beagle dogs were given ochratoxin A (0.1 and 0.2 mg/kg) and citrinin ( 5 and 10 mg/kg) alone and in two dose combinations for 14 days. The gross lesions included focal peritonitis and intestinal intussusceptions in dogs given citrinin. Changes in the kidneys of dogs given ochratoxin A were degeneration and necrosis with desquamation of tubular epithelial cells, primarily in the straight segment of the proximal tubules. Dogs given 10 mg/kg citrinin had similar changes in the distal tubules and collecting ducts. Dogs given combined doses of citrinin and ochratoxin A had degeneration and necrosis in proximal and distal tubules, and in thin segments and the collecting ducts; there were desquamated cells and granular casts in the lumina. Dogs given ochratoxin A had necrosis of lymphoid tissues in the spleen, tonsil, thymus, peripheral lymph nodes and lymph nodules of the ileum, colon and rectum. There was ulceration of the mucosa of the intestine in dogs given large combined doses of ochratoxin A and citrinin.The clinical and clinicopathologic features of the mycotoxicoses produced in Beagle dogs by administration of ochratoxin A and citrinin alone and in combination have been described [13]. Pathologic changes induced by ochratoxin A in several species including the rat [19, 20, 23, 24, 27, 281, pig [14][15][16] 251 [22, 271, chick [6, 10, 211 and hen [4] have been described. Changes included renal tubular necrosis, hepatic and lymphoid necrosis and intestinal ulceration.In previous reports of citrinin toxicosis the proximal convoluted tubules of kidneys were changed in all species studied [1, 21. In the dog, renal lesions of citrinin toxicosis included degeneration and necrosis of the tubular epithelium, primarily of the straight segments and distal convoluted tubules [ 3 ] .This report describes changes in dogs given ochratoxin A , citrinin and the two mycotoxins in combination.
Materials and MethodsThirty five 10-week-old male Beagle dogs were purchased for the six trials of this study. They were given daily oral doses of either ochratoxin A or daily intraperitoneal injections of citrinin dissolved in absolute ethanol or in combination, according to the dosage regimen in table I. Control dogs were dosed with ethanol. The dogs were housed in metabolism cages and blood was taken periodically for 261